[尿酸,认知障碍,神经退行症]
M S Eliseev1, O V Zheliabina1, E L Nasonov1,2
1Nasonova Research Institute of Rheumatology.
Terapevticheskii arkhiv
|June 3, 2024
概括
尿酸 (UA) 显示出潜在的神经保护性质,影响认知功能和神经退行. 需要进一步的研究来确定最佳的UA水平来预防认知障碍.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 老年学是一门学科.
背景情况:
- 尿酸 (UA) 是人体中一个关键的抗氧化剂.
- 它作为抗氧化剂和抗氧化剂的双重作用与神经退行性疾病有关.
- 血清UA水平与认知健康相关的研究越来越多.
研究的目的:
- 检查尿酸在认知变化和神经退行症中的作用.
- 探索UA在大脑中的抗氧化和抗氧化功能.
- 了解血清UA水平与认知障碍之间的关系.
主要方法:
- 对调查尿酸和认知功能研究的文献综述.
- 对UA在阿尔茨海默氏症等神经退行性疾病中的作用的研究分析.
- 检查UA的抗氧化和抗氧化活性之间的平衡.
主要成果:
- 血清UA水平的变化与认知障碍的发展或延迟有关.
- UA 呈现出潜在的神经保护性质,影响认知功能动态.
- UA的抗氧化/抗氧化作用的平衡对于神经元的保护至关重要.
结论:
- 尿酸代谢与大脑健康和认知过程有关.
- 进一步的研究是必不可少的,以澄清UA的复杂作用,并建立最佳水平.
- 了解UA的影响可能会导致预防认知衰退的新策略.
相关概念视频
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Role of Neurotransmitters in Memory
523
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
523
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110


